ARCHIVES

Clinical Trials: Stories On Results Can Have Unintended Consequences

This article is from The Cancer Letter archive.

Vol. 24 No. 19 | May 15, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: Reauthorization Bill Could Go To House Floor Next Week; Packwood Blocks Action In Senate

July 8, 1983

EORTC Places Same Number on Phase 2-3 Trials As In U.S.

December 12, 1986

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

SWOG Trial Reports Longest Survival To Date For NSCLC

June 29, 2001

In Brief: George Vande Woude To Wistar institute Board; Donald Pinkel To Head Pediatric Leukemia Program

October 18, 1985

Southern Screening Contract Now at $2 Mil. Year For Five Year

June 7, 1974